Authored By: Sarah
11 Jul 2024

 Antibiotics Market to grow by USD 16631.3 million between 2024-2028

According to a research report “ Antibiotics Market” by Product (Broad-spectrum antibiotics, Narrow-spectrum antibiotics) Route Of Administration (Intravenous, Oral, Others) Geography (Asia, North America, Europe, Rest of World (ROW))- Global Forecast to 2028 published by Technavio, the market size is estimated to grow by USD 16631.3 million at a CAGR of over 5.67% during the forecast period. The global surge in infectious diseases, driven by pathogen proliferation and transmission, poses a significant challenge for the antibiotics market. Urbanization and demographic shifts, characterized by population density and ecosystem degradation, have facilitated the spread of these diseases. Consequently, the demand for effective antibiotic solutions to combat these health threats continues to grow..

Browse market data tables, figures, and in-depth TOC on “Antibiotics Market” by Product (Broad-spectrum antibiotics, Narrow-spectrum antibiotics) Route Of Administration (Intravenous, Oral, Others) Geography (Asia, North America, Europe, Rest of World (ROW)) Global Forecast to 2028.

 View detailed Table of Content- Click here

By Product, the Broad-spectrum antibiotics segment is projected to dominate the market size in 2024.

ai_market_segmentation_by

By Route Of Administration, Intravenous  segment is expected to hold the largest market size for the year 2024.

In the antibiotics market, broad-spectrum antibiotics hold a significant share due to their efficacy against a diverse array of microorganisms, including Gram-positive and Gram-negative bacteria. These drugs are invaluable in instances where narrow-spectrum antibiotics fail to produce results or when the infecting agent remains unidentified, particularly in serious illnesses or multi-bacterial infections. Notable broad-spectrum antibiotics include amoxicillin, levofloxacin, gatifloxacin, streptomycin, tetracycline, and chloramphenicol. The market's growth is driven by the broad-spectrum antibiotics' extensive therapeutic applications against various microbial infections. However, the overuse of these agents contributes to the emergence of antibiotic resistance, posing a significant challenge to the industry.

Asia is forecasted to hold the largest market size by region in 2024.

The Antibiotics Market represents a significant business opportunity, driven by the increasing prevalence of bacterial infections and the resulting demand for effective antibiotic treatments. Key market trends include the development of novel antibiotics to combat antibiotic resistance, the growth of the generics segment, and the expanding use of antibiotics in animal health. Companies in this sector must navigate regulatory challenges and invest in research and development to stay competitive.

The Antibiotics Market t growth and forecasting report also includes detailed analyses of the competitive landscape of the market growth and forecasting and information about 20 market companies, including:

  • Abbott Laboratories
  • AbbVie Inc.
  • Armata Pharmaceuticals Inc.
  • Aspen Pharmacare Holdings Ltd.
  • Astellas Pharma Inc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • F. Hoffmann La Roche Ltd.
  • Flynn Pharma Ltd.
  • GlaxoSmithKline Plc
  • Incepta Pharmaceuticals Ltd.
  • Johnson and Johnson Services Inc.
  • Lupin Ltd.
  • Mayne Pharma Group Ltd.
  • Melinta Therapeutics LLC
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.
.

For insights on company offerings- Request a sample report!

Research Analysis Overview

The Antibiotics market encompasses a wide range of pharmaceutical products designed to combat various bacterial infections, including respiratory infections, gastrointestinal infections, urinary tract infections, skin infections, and septicemia. Antimicrobial resistance poses a significant challenge in this market, with bacterial strains developing resistance to narrow-spectrum antibiotics like Tetracyclines and Suifonamides. In response, the industry has turned to broad-spectrum antibiotics such as Aminoglycosides, Fluoroquinolones, Macrolides, Penicillin, and Cephalosporin. Clinical trials are ongoing to develop new Antibacterial drugs to combat multi-drug resistant bacteria and pathogenic bacteria. Antibiotic resistance is a pressing issue, with concerns over the long-term effectiveness of current antibiotics. Definitive Healthcare data indicates that the global Antibiotics market size is expected to grow significantly in the coming years, driven by the increasing prevalence of bacterial infections and the need for effective antibiotics to combat antibiotic resistance.

Market Research Overview

The Antibiotics market encompasses a wide range of pharmaceutical products used to treat various infections, including respiratory infections, gastrointestinal infections, urinary tract infections, skin infections, and hospital-acquired diseases caused by both Gram-negative and Gram-positive bacteria. Key antibiotic classes include Aminoglycosides, Fluoroquinolones, Suifonamides, Microlides, Tetracyclines, and Macrolides, among others. Companies such as Xediton Pharmaceuticals, Pattern Bioscience, Bugworks Research, Wockhardt, Spero Therapeutics, Sinovent, Selmod49, RedHill Biopharma, MicuRx Pharmaceuticals, Meiji Seika Pharma, Madam Therapeutics, Helperby Therapeutics, Fujisawa Pharmaceutical, Fedora Pharmaceuticals, Crestone, and several others are actively involved in the development and commercialization of antibacterial drugs. The market is currently facing a significant challenge due to the rising issue of antimicrobial resistance, which necessitates the development of narrow-spectrum and broad-spectrum antibiotics to combat multi-drug resistant bacteria and pathogenic bacteria. Clinical trials are underway to evaluate the efficacy and safety of new antibiotic candidates from various organizations, including Janssen, Melinta Therapeutics, Merck, GlaxoSmithKline, and Biocidium Biopharmaceuticals.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!
Technavio